Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
The Alliance for Clinical Trials in Oncology thrives on the dedication, vision, and expertise of its leadership team. We express our deep gratitude to the outgoing committee chairs whose years of tireless service have fundamentally shaped our research portfolio, advanced clinical trials, and mentored the next generation of investigators while profoundly impacting the lives of…
E-News – June 2026Alliance Research Update Recently Activated Alliance Trials The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new radiation therapy techniques for lung cancer to treatments for breast cancer side effects, these trials…
Each year, about 85,000 adolescents and young adults (AYA) between the ages of 15 and 39 are diagnosed with cancer in the United States. According to the National Cancer Institute, this represents about 4% of all new cancer diagnoses. Depending on age and specific diagnosis, many AYA people with cancer may be treated at either…
A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma, a type of brain cancer. Supported in part by a grant from the National Cancer Institute, the study (Alliance A072301) will…
Categories
Alliance Committee
Browse by Year